PLEASANTON, CA — Oct. 21, 2013 – Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud software solutions for life sciences, today announced the closing of its previously announced initial public offering of 15,001,750 shares of its Class A common stock at a price to the public of $20.00 per share, which included 1,956,750 shares issued upon the exercise in full of the underwriters’ option to purchase additional shares. A total of 11,676,750 shares were sold by Veeva and a total of 3,325,000 shares were sold by certain selling stockholders. Veeva did not receive any proceeds from the sale of shares by the selling stockholders.
The shares began trading on the New York Stock Exchange on Oct. 16, 2013 under the symbol “VEEV.”
Morgan Stanley & Co. LLC and Deutsche Bank Securities Inc. acted as joint book-running managers for the offering. Pacific Crest Securities LLC; Stifel, Nicolaus & Company, Incorporated; Wells Fargo Securities, LLC; and Canaccord Genuity Inc. acted as co-managers.
A registration statement relating to these securities has been filed with the Securities and Exchange Commission and was declared effective on Oct. 15, 2013. The offering is being made only by means of a prospectus. A copy of the final prospectus relating to the offering may be obtained from: Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014, or by calling (866) 718-1649, or by emailing a request to prospectus@morganstanley.com; or from Deutsche Bank Securities Inc., Attention: Prospectus Department, 60 Wall Street, New York, New York 10005-2836, or via telephone at (800) 503-4611, or email at prospectus.cpdg@db.com.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About Veeva Systems
Veeva Systems is a leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva has more than 170 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. Founded in 2007, Veeva is headquartered in the San Francisco Bay Area, with offices in Philadelphia, Barcelona, Budapest, London, Paris, Beijing, Shanghai, Osaka, Tokyo, Sydney, and Singapore. For more information, visit www.veeva.com.